Skip to main content
. 2006 Feb;50(2):445–452. doi: 10.1128/AAC.50.2.445-452.2006

FIG. 1.

FIG. 1.

Borrelia burgdorferi 16S rRNA secondary-structure model. Enlarged regions show point mutations that confer resistance to spectinomycin (A1185 and C1186) and kanamycin or gentamicin (A1402). (Adapted from http://www.rna.icmb.utexas.edu/ [11] with permission.)